Our data, together with what has been observed in esophageal carcinoma [16, 17], hypopharyngeal carcinoma [14], and oral carcinoma [15, 18], would suggest that the percent of CD44+CD271+ cells might also provide prognostic information. The gene discussed is NGFR; the disease is hypopharyngeal carcinoma.